These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12353228)

  • 21. p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo.
    Perez-Losada J; Wu D; DelRosario R; Balmain A; Mao JH
    Oncogene; 2005 Aug; 24(35):5521-4. PubMed ID: 16007185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation of a 5' CpG island of p16 is a frequent event in non-Hodgkin's lymphoma.
    Martinez-Delgado B; Fernandez-Piqueras J; Garcia MJ; Arranz E; Gallego J; Rivas C; Robledo M; Benitez J
    Leukemia; 1997 Mar; 11(3):425-8. PubMed ID: 9067584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation of the p73 gene in gliomas.
    Watanabe T; Huang H; Nakamura M; Wischhusen J; Weller M; Kleihues P; Ohgaki H
    Acta Neuropathol; 2002 Oct; 104(4):357-62. PubMed ID: 12200621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coincidental LOH regions in mouse and humans: evidence for novel tumor suppressor loci at 9q22-q34 in non-Hodgkin's lymphomas.
    Meléndez B; Cuadros M; Robledo M; Rivas C; Fernández-Piqueras J; Martínez-Delgado B; Benítez J
    Leuk Res; 2003 Jul; 27(7):627-33. PubMed ID: 12681362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation.
    Valleley EM; Cordery SF; Carr IM; MacLennan KA; Bonthron DT
    Genes Chromosomes Cancer; 2010 May; 49(5):480-6. PubMed ID: 20175198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 and p73 in suppression of Myc-driven lymphomagenesis.
    Griesmann H; Schlereth K; Krause M; Samans B; Stiewe T
    Int J Cancer; 2009 Jan; 124(2):502-6. PubMed ID: 18942718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
    Møller MB; Nielsen O; Pedersen NT
    Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma.
    Peng CY; Tsai SL; Yeh CT; Hung SP; Chen MF; Chen TC; Chu CM; Liaw YF
    Anticancer Res; 2000; 20(3A):1487-92. PubMed ID: 10928060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas.
    Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
    Med Pediatr Oncol; 2001 Jan; 36(1):42-4. PubMed ID: 11464902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target.
    Imyanitov EN; Birrell GW; Filippovich I; Sorokina N; Arnold J; Mould MA; Wright K; Walsh M; Mok SC; Lavin MF; Chenevix-Trench G; Khanna KK
    Oncogene; 1999 Aug; 18(32):4640-2. PubMed ID: 10467409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development.
    Ejeskär K; Sjöberg RM; Kogner P; Martinsson T
    Int J Mol Med; 1999 Jun; 3(6):585-9. PubMed ID: 10341287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse p73 gene maps to the distal part of chromosome 4 and might be involved in the progression of gamma-radiation-induced T-cell lymphomas.
    Herranz M; Santos J; Salido E; Fernández-Piqueras J; Serrano M
    Cancer Res; 1999 May; 59(9):2068-71. PubMed ID: 10232589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in Japanese.
    Hishida A; Matsuo K; Tajima K; Ogura M; Kagami Y; Taji H; Morishima Y; Emi N; Naoe T; Hamajima N
    Leuk Lymphoma; 2004 May; 45(5):957-64. PubMed ID: 15291355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of WWOX alterations on p73, ΔNp73, p53, cell proliferation and DNA ploidy in salivary gland neoplasms.
    Gomes CC; Diniz MG; Oliveira CS; Tavassoli M; Odell EW; Gomez RS; De Marco L
    Oral Dis; 2011 Sep; 17(6):564-71. PubMed ID: 21332605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional inactivation of TP73 expression in oligodendroglial tumors.
    Dong S; Pang JC; Hu J; Zhou LF; Ng HK
    Int J Cancer; 2002 Mar; 98(3):370-5. PubMed ID: 11920588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.
    Nicholson SA; Okby NT; Khan MA; Welsh JA; McMenamin MG; Travis WD; Jett JR; Tazelaar HD; Trastek V; Pairolero PC; Corn PG; Herman JG; Liotta LA; Caporaso NE; Harris CC
    Cancer Res; 2001 Jul; 61(14):5636-43. PubMed ID: 11454718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the putative tumour suppressor gene, p73, in neuroblastoma and other childhood tumours.
    Norris MD; Gilbert J; Smith SA; Marshall GM; Salwen H; Cohn SL; Haber M
    Med Pediatr Oncol; 2001 Jan; 36(1):48-51. PubMed ID: 11464904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.
    Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
    Oncogene; 1999 Jan; 18(4):1061-6. PubMed ID: 10023682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of mutation of the p73 gene in astrocytic neoplasms.
    Alonso ME; Bello MJ; Lomas J; Gonzalez-Gomez P; Arjona D; De Campos JM; Gutierrez M; Isla A; Vaquero J; Rey JA
    Int J Oncol; 2001 Sep; 19(3):609-12. PubMed ID: 11494043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia.
    Rossi D; Capello D; Gloghini A; Franceschetti S; Paulli M; Bhatia K; Saglio G; Vitolo U; Pileri SA; Esteller M; Carbone A; Gaidano G
    Haematologica; 2004 Feb; 89(2):154-64. PubMed ID: 15003890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.